Latest Sunitinib Stories
By JEREMY LAURANCE The big question Why are we asking this now? CANCER CHARITIES, kidney specialists and campaigners were outraged yesterday when the National Institute for Clinical Excellence (Nice), announced that it had rejected four new drugs for advanced kidney cancer as too expensive for the NHS.
By JANE KIRBY PATIENTS with advanced kidney cancer will be denied four treatments on the NHS under new guidelines published yesterday.
By Greg Tindle A WELSH cancer expert has described as "an outrage" plans to deny patients with advanced kidney cancer four types of drug treatment on the NHS.
By Emma Brady Midland cancer experts have hit out at a decision to deny kidney cancer patients four drugs under new NHS guidelines issued yesterday.
By HELEN RAE PATIENTS with advanced kidney cancer will be denied four life- extending treatments on the NHS because they are not cost effective.
PATIENTS with advanced kidney cancer will be denied four treatments on the NHS under new guidelines published today.
By JANE KIRBY Broadcaster James Whale accused a health watchdog today of being "barbaric" in denying kidney cancer patients access to four drugs.
By Barry Nelson PATIENTS with advanced kidney cancer were dealt a devastating blow last night when spending watchdogs effectively banned four life- giving drugs on the NHS.
By Ashley Andyshak, The Frederick News-Post, Md. Aug. 2--Frederick Memorial Hospital Regional Cancer Therapy Center has received a $30,000 grant to improve its clinical research programs.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that the State Food and Drug Administration of China has approved Nexavar tablets for the treatment of patients with unresectable or metastatic hepatocellular carcinoma, or liver cancer.
- Growing in low tufty patches.